Laxio Arenas et al., 2024 - Google Patents
Composition and Conformation of Hetero‐versus Homo‐Fluorinated Triazolamers Influence their Activity on Islet Amyloid Polypeptide AggregationLaxio Arenas et al., 2024
View PDF- Document ID
- 7381493433923383931
- Author
- Laxio Arenas J
- Lesma J
- Ha‐Duong T
- Ranjan Sahoo B
- Ramamoorthy A
- Tonali N
- Soulier J
- Halgand F
- Giraud F
- Crousse B
- Kaffy J
- Ongeri S
- Publication year
- Publication venue
- Chemistry–A European Journal
External Links
Snippet
Novel fluorinated foldamers based on aminomethyl‐1, 4‐triazolyl‐difluoroacetic acid (1, 4‐ Tz− CF2) units were synthesized and their conformational behaviour was studied by NMR and molecular dynamics. Their activity on the aggregation of the human islet amyloid …
- 238000004220 aggregation 0 title abstract description 47
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Cody et al. | Design of a potent combined pseudopeptide endothelin-A/endothelin-B receptor antagonist, Ac-DBhg16-Leu-Asp-Ile-[NMe] Ile-Trp21 (PD 156252): examination of its pharmacokinetic and spectral properties | |
White et al. | On-resin N-methylation of cyclic peptides for discovery of orally bioavailable scaffolds | |
EP3280723B1 (en) | Backbone-cyclized peptidomimetics | |
Farrera-Sinfreu et al. | A New Class of Foldamers Based on cis-γ-Amino-l-proline1, 2 | |
Balayssac et al. | Comparison of penetratin and other homeodomain-derived cell-penetrating peptides: interaction in a membrane-mimicking environment and cellular uptake efficiency | |
Cardillo et al. | Endomorphin-1 analogues containing β-proline are μ-opioid receptor agonists and display enhanced enzymatic hydrolysis resistance | |
Melendez et al. | Aza-amino acid scan for rapid identification of secondary structure based on the application of N-Boc-Aza1-dipeptides in peptide synthesis | |
Brouwer et al. | Peptido sulfonyl fluorides as new powerful proteasome inhibitors | |
Scrima et al. | CuI‐catalyzed azide–alkyne intramolecular i‐to‐(i+ 4) side‐chain‐to‐side‐chain cyclization promotes the formation of helix‐like secondary structures | |
Jacobsen et al. | Stapling of a 310-helix with click chemistry | |
Phillips et al. | “@-Tides”: The 1, 2-Dihydro-3 (6 H)-pyridinone Unit as a β-Strand Mimic | |
March et al. | Substrate-based cyclic peptidomimetics of Phe-Ile-Val that inhibit HIV-1 protease using a novel enzyme-binding mode | |
EP2320927B1 (en) | Modified peptides as potent inhibitors of the psd-95/nmda receptor interaction | |
Bergmann et al. | Multivalency effects on Pseudomonas aeruginosa biofilm inhibition and dispersal by glycopeptide dendrimers targeting lectin LecA | |
US10000535B2 (en) | Template-fixed peptidomimetics | |
Byk et al. | Synthesis and biological activity of NK-1 selective, N-backbone cyclic analogs of the C-terminal hexapeptide of substance P | |
Rzepecki et al. | β-sheet ligands in action: KLVFF recognition by aminopyrazole hybrid receptors in water | |
YAMAZAKI et al. | Biological and conformational studies of [Val4] morphiceptin and [D‐Val4] morphiceptin analogs incorporating cis‐2‐aminocyclopentane carboxylic acid as a peptidomimetic for proline | |
Wang et al. | Synthesis of peptide disulfide-bond mimics by using fully orthogonally protected diaminodiacids | |
Vidovic et al. | Chloride-assisted peptide macrocyclization | |
BR122019016211B1 (en) | COMPOUND, PHARMACEUTICAL COMPOSITION, USE OF THE COMPOUND AND PROCESS FOR THE MANUFACTURE OF THE SAME | |
Tömböly et al. | Structure− activity study on the Phe side chain arrangement of endomorphins using conformationally constrained analogues | |
Doan et al. | Solid‐phase synthesis of C‐terminal azapeptides | |
Lesma et al. | β-Hairpin peptide mimics decrease human islet amyloid polypeptide (hIAPP) aggregation | |
Parthasarathy et al. | The medicinal chemistry of therapeutic peptides: Recent developments in synthesis and design optimizations |